Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pancreatic lipase-IN-2
Cat. No.:
OB0425LY-210
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Pancreatic lipase-IN-2 is an enzyme inhibitor that specifically targets pancreatic lipase to inhibit fat digestion and absorption.
Synonyms:
Pancreatic lipase-IN-2; Pancreatic lipase IN 2; Pancreatic lipase inhibitor 2
Formula:
C32H33N3O2S
Formula Weight:
523.69
Specification
Target:
Lipase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Pancreatic lipase-IN-2 can be used for research on the treatment of obesity and hyperlipidemia, and for the development of weight loss drugs. The inhibitor can also be used to develop novel anti-obesity drugs.
